3M Drug Delivery Systems Grows Partnerships in Asia
recently advanced its participation in the Asian market with a sponsorship of
the Asia Pharma R&D Leaders 2010 event, held
The event, organized by Global Leaders Institute, the leading life science
event producer in
professionals, policymakers, and academics to discuss
manufacturing, research and development of today’s drug and biotech
innovations, as well as opportunities for future growth.
3M Drug Delivery Systems is playing an active role in the growth of the
pharmaceutical industry in
laboratory facility at the 3M
Drug Delivery Systems’ first contract research and development facility in the
country’s infrastructure makes it an ideal hub for 3M’s
and
drug delivery categories, bringing 3M’s innovative inhalers and patches to
pharmaceutical customers and patients in the
Research conducted at the
Delivery Systems’ growing capabilities and product portfolio. Since its
invention of the metered-dose inhaler (MDI) 50 years ago, the company has
remained a pioneer in the technology and now offers a full suite of MDI
development and manufacturing capabilities and components, including the 3M(TM)
Integrated Dose by Dose Counter. Additional technologies are available to
improve patient experiences and help ensure the technical success of clients’
products.
Other recent offerings in inhalation include the 3M(TM) Taper Dry Powder
Inhaler, which stores API on a microstructured carrier tape, virtually
eliminating the need for lactose or complex powder formulations as well as 3M
Conix(TM) Dry Powder Inhaler, which uses reverse-flow cyclone technology to
enable a patient’s inhalation to efficiently aerosolize the drug. The company
has also recently introduced two new inhaler components, the 3M(TM) Face Seal
Valve, which eliminates the need to prime an inhaler, and 3M(TM) Plasma
Coating Technology, which provides protection from degradation, deposition and
corrosion.
In addition to its inhalation and transdermal technologies, the company
also offers a portfolio of TLR-based vaccine adjuvants, as well as services in
Transdermal components, packaging films and manufacturing. In addition to its
as well as manufacturing sites in the US, UK, and
For more information, visit http://www.3M.com/dds .
About 3M Drug Delivery Systems
3M Drug Delivery Systems partners with pharmaceutical and biotech
companies to develop pharmaceuticals using 3M’s inhalation or transdermal drug
delivery technology. 3M offers a full range of feasibility, development and
manufacturing capabilities combined with regulatory guidance to help bring
products to market. In-house resources, including toxicology, regulatory
expertise, quality assurance, operations, and marketed product support, are
available for each step of the development and commercialization process. This
depth of resources is one reason why more than 50 percent of all metered-dose
inhalers worldwide and 80 percent of all transdermal systems in
States
visit http://www.3M.com/dds or call 1-800-643-8086.
About 3M Health Care
3M Health Care, one of 3M’s six major business segments, provides world-
class innovative products and services to help health care professionals
improve the practice, delivery and outcome of patient care in medical, oral
care, drug delivery and health information markets.
3M is a trademark of 3M Company.
About Global Leaders Institute
Global Leaders Institute is the producer and organizer of top-level
business events. We focus on the development and operation of the strategic,
market leading business conference. We focus on the specialty spirit and
professional attainment. We focus on value creation for our client. We
provide 60 annual conferences across energy, finance, transportation, life
science, real estate, telecom and media, etc. each year. For more information,
please visit http://www.globaleaders.com .
For further information, please contact:
Michael Gugala
Karwoski & Courage
Tel: +1-612-342-9604
Email: m.gugala@creativepr.com
SOURCE Global Leaders Institute
